Biotechnology Company NEUROKIN Strengthens its Board of Directors and Scientific Committee

The neuroprotective drugs development company announces today the appointment of two former Vice Presidents of Sanofi - Aventis; Bernard Reculeau, and Jesús Benavides.

scientist studying neurons

Epilepsy

 

Post-traumatic seizures can appear frequently after a severe traumatic brain injury (TBI). Two types of seizures are usually identified: early seizures during the week following the trauma and late epilepsy afterward. Neurokin is interested in the last indication.


TBI causes epilepsy in up to 30% of civilian and 50% of military head injuries, exacerbating chronic neurological disability.

No treatment is available to prevent epilepsy after traumatic brain injury.

 


Featured links

scientist studies neurons cardiac arrest